Indeed, some SCLC cell lines are resistant to CHK1 inhibition, and in resistant cells generated through treatment with increasing doses of prexasertib, WEE1 G2 checkpoint kinase (WEE1) upregulation was identified as a mediator of resistance [173]. This evidence concerns the gene WEE1 and small cell lung carcinoma.